Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04614103
Title Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Iovance Biotherapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | DEU | CHE | CAN

Additional content available in CKB BOOST